文献速递瓣膜外科主动脉外科

白塞病合并重度主动脉瓣反流的手术结局

Surgical Outcomes in Behcet's Disease Patients With Severe Aortic Regurgitation.
PubMed 文献 · Ann Thorac Surg · 2018-10-10

本研究评估了23例因重度主动脉瓣反流接受手术的白塞病患者,比较不同术式、人工材料及免疫调节治疗对手术结局的影响。结果显示机械瓣根部替换组术后不良事件发生率最低(33%),多因素分析表明机械瓣根部替换是术后无事件生存的最显著预测因素(HR 0.147,95%CI 0.028-0.766,P=0.023),出院后1个月CRP水平和手术年龄也是独立预测因素。

要点

  • 机械瓣根部替换组术后不良事件发生率(33%)低于孤立主动脉瓣置换(73%)和生物瓣根部替换(75%)。
  • 机械瓣根部替换是术后无事件生存的最显著预测因素(HR 0.147,95%CI 0.028-0.766,P=0.023)。
  • 出院后1个月CRP水平和手术年龄是术后无事件生存的独立预测因素。

核心结论

  • 机械瓣根部替换联合术后免疫调节治疗维持低CRP水平,可能为白塞病合并重度主动脉瓣反流患者带来最佳手术结局。

研究设计与样本

  • 本研究评估了23例因主动脉瓣反流接受手术治疗的白塞病患者。
  • 研究回顾了35例手术病例(40例手术中排除4例病历记录不完整和1例心脏移植)。
  • 手术方式分为孤立主动脉瓣置换、生物瓣根部替换(含同种瓣)和机械瓣根部替换。

主要发现

  • 术后显著不良事件在孤立主动脉瓣置换组为8/11(73%),生物瓣根部替换组为9/12(75%),机械瓣根部替换组为4/12(33%)。
  • 多因素分析显示出院后1个月CRP水平和手术年龄是术后无事件生存的独立预测因素。
  • 机械瓣根部替换是术后良好结局的最显著预测因素(HR 0.147,95%CI 0.028-0.766,P=0.023)。

临床怎么用

  • 对于白塞病合并重度主动脉瓣反流患者,可优先考虑机械瓣根部替换术式。
  • 术后应通过辅助免疫调节治疗维持低CRP水平,以改善手术结局。

局限性

  • 本研究样本量小(23例患者,35例手术),为回顾性分析。
  • 4例病历记录不完整和1例心脏移植被排除,可能影响结果代表性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An optimal treatment for aortic regurgitation in Behcet's disease has not been established. We investigated the effect of operative technique, prosthetic material, and immunomodulation therapy on surgical outcomes. METHODS: In this study, 23 patients with Behcet's disease surgically treated for aortic regurgitation were assessed. Significant postoperative events were defined as death, aortic valve or graft-related problem(s), infective endocarditis, disabling stroke, and aortic valve or root reoperation. Surgical procedures were classified as isolated aortic valve replacement, bioprosthetic root replacement, and mechanical root replacement. Allograft root replacements were included in the bioprosthetic root replacement group. RESULTS: A total of 40 operations, including 39 aortic valve or root surgeries and 1 orthotopic heart transplantation, were performed on patients confirmed with Behcet's disease. However, the study only reviewed 35 of the 40 cases (4 cases with inadequately documented medical records and 1 heart transplantation case were excluded). Significant adverse events occurred in 8 of 11 (73%) isolated aortic valve replacement, 9 of 12 (75%) bioprosthetic root replacement (5 xenografts and 7 allografts), and 4 of 12 (33%) mechanical root replacement cases. Multivariate analysis revealed that the 1-month postdischarge C-reactive protein level and operative age were independent predictive factors for postoperative event-free survival. Mechanical root replacement was identified as the most significant predictive factor leading to positive outcomes (hazard ratio, 0.147; 95% confidence interval, 0.028 to 0.766; p = 0.023). CONCLUSIONS: The findings suggest that mechanical root replacement combined with a low postoperative C-reactive protein level maintained through adjunctive immunomodulation therapy may lead to optimal surgical outcomes in Behcet's disease associated with severe aortic regurgitation.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ghang B, Kim JB, Jung SH, et al. Surgical Outcomes in Behcet's Disease Patients With Severe Aortic Regurgitation. Ann Thorac Surg. 2018. PMID: 30315793. doi:10.1016/j.athoracsur.2018.08.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。